Cohance Lifesciences Ltd
SUVENPHAR
Company Profile
Business description
Cohance Lifesciences Ltd is a CDMO and API platform, offering products and services across all phases of a molecule’s lifecycle from development to commercialization. Its Business Units comprise: CDMO, API+ and Formulations, and Clinical and Analytical Services.
Contact
Hitech City Road, Panmaktha Plot, 1
202, 2nd Floor, B-Wing, Galaxy by Aurobindo Realty, Sy No 83/1
Hyderabad Knowledge City TSIIC Raidurg
Opposite IKEA
HyderabadTG500081
INDT: +91 4044758595
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
1,052
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,422.80 | 23.00 | 0.27% |
| CAC 40 | 7,626.84 | 70.08 | -0.91% |
| DAX 40 | 23,115.96 | 133.69 | -0.58% |
| Dow JONES (US) | 41,113.97 | 284.97 | 0.70% |
| FTSE 100 | 8,559.33 | 38.09 | -0.44% |
| HKSE | 22,853.42 | 161.54 | 0.71% |
| NASDAQ | 17,738.16 | 48.50 | 0.27% |
| Nikkei 225 | 36,950.14 | 170.48 | 0.46% |
| NZX 50 Index | 12,467.03 | 29.86 | -0.24% |
| S&P 500 | 5,631.28 | 24.37 | 0.43% |
| S&P/ASX 200 | 8,193.00 | 14.70 | 0.18% |
| SSE Composite Index | 3,352.82 | 10.15 | 0.30% |